Pfizer LC/UV/MS Data Processing Case Study

This case study outlines the challenges faced by Pfizer's Pharmaceutical Sciences Small Molecule (PSSM) team regarding inefficient and non-standardized processing, analysis, and reporting of LC/UV/MS data. The team dealt with various instruments and software packages, leading to difficulties in data management and a lack of standardization. To address these issues, Pfizer transitioned to Agilent instruments and implemented the MS Workbook Suite, which is built on the Spectrus platform. This new workflow introduced semi-automated processing and analysis capabilities, significantly reducing the time required for data processing from 5–10 minutes per sample to just 1–2 minutes. The case study details how this transformation has led to increased efficiency, allowing scientists to focus on more valuable tasks. Additionally, the team plans to expand the use of the software and its databasing capabilities to further enhance data management and workflow efficiency in the future.